PFE

Vaccine hope driven by data from Novavax and J&J, but fears about new variants remain

Novavax’s stock rises as its Covid-19 vaccine outpaces J&J

Pfizer Covid-19 vaccine works against mutations found in the UK, South Africa variants, laboratory study results

WHO recommends against Moderna, Pfizer vaccines for most pregnant women

Pfizer (PFE), BioNTech to boost Covid-19 vaccine production with Sanofi Deal

It was a dark morning in the Covid-19 fight. The market is looking for hope at Johnson & Johnson.

J&J can share findings from the Phase 3 vaccine trial this week

CDC: Moderna’s COVID-19 vaccine may cause allergic reaction in some people

Merck Scrap Covid-19 Vaccine Candidates

California officials investigate death of person who received the Covid-19 vaccine hours earlier

Johnson & Johnson targets 100 million doses of vaccine by spring. The stock market is counting on that.

Studies of South African coronavirus strains raise concerns about immune response